A 39-year-old man was admitted to our hospital with a severe headache. He had a 2-year history of hypertension. No pathology was detected in the gastrointestinal and respiratory system examination. The blood pressure was 170/110 mmHg. Abdominal ultrasound revealed grade 1 increase in bilateral renal parenchyma echogenicity. The BUN was 69.6 mg/dl, creatinine 2.29 mg/dl, and phosphorus 4.61 mg/dl. Other biochemical parameters were normal. Renal parenchymal changes and laboratory results were compatible with hypertensive nephropathy. Doppler ultrasound found no renal vascular pathology. The hemoglobin value was low (10.2 g/day). Cranial magnetic resonance imaging (MRI) also showed pathological signal changes in parieto-occipital localization. In addition, hyperintensity and expansile appearance were observed in the mesencephalon, pons and middle cerebellar peduncle (Fig. 1). In MR spectroscopy, there was not any pathology other than minimal prominence in the choline peak. There were not any pathologic findings in diffusion-weighted images (DWI) and gradient echo sequences. On the basis of clinical and imaging examination, a diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) with brainstem involvement was made. Clinical findings were improved after the patient was hospitalized, and treatment was started. After 20 days, it was observed that the radiological changes completely disappeared on MRI.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.